Rapid androgen-responsive proteome is involved in prostate cancer progression

3Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Androgen exerts its functions by binding with an androgen receptor (AR). It can activate many signaling pathways that are important to the progression of castration-resistant prostate cancer (CRPC). Here, we characterized the rapid proteomic changes seen at 5, 15, 30, and 60 min after the androgen treatment of VCaP cells via the tandem mass tag (TMT) labeling strategy. A total of 5529 proteins were successfully identified and quantified. Dynamic time profiling of protein expression patterns allowed us to identify five protein clusters involved in various stages of androgen-initiated signal transmission and processing. More details of protein functions and localization patterns, and our elucidation of an AR-interacting protein network, were obtained. Finally, we validated the expression level of AR-regulated proteins known to be significantly regulated in CRPC patients using the mouse xenograft model and patient samples. Our work offers a systematic analysis of the rapid proteomic changes induced by androgen and provides a global view of the molecular mechanisms underlying CRPC progression.

Cite

CITATION STYLE

APA

Kim, J. K., Jung, J. H., Shin, D. H., You, H. J., Cha, S., Song, B. S., … Myung, J. K. (2021). Rapid androgen-responsive proteome is involved in prostate cancer progression. Biomedicines, 9(12). https://doi.org/10.3390/biomedicines9121877

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free